18 Diabetic Patients Implanted With VeriMed RFID Microchip at Atlanta Diabetes EXPO
March 12 2007 - 12:23PM
PR Newswire (US)
VeriChip Corporation enhances focus on diabetic community and
partnering with American Diabetes Association DELRAY BEACH, Fla.,
March 12 /PRNewswire-FirstCall/ -- VeriChip Corporation
(NASDAQ:CHIP), a provider of RFID systems for healthcare and
patient-related needs, announced today it added 18 diabetic
patients to its VeriMed Patient Identification System at an Atlanta
Diabetes EXPO sponsored by the American Diabetes Association (ADA).
At the Diabetes EXPO, physicians implanted VeriMed RFID microchips
in conference attendees who signed up for the voluntary procedure.
The VeriMed Patient Identification System, which utilizes an
implantable RFID microchip in combination with a handheld RFID
scanner and a secure patient database, provides immediate access to
important health information for patients who arrive at an
emergency department unable to communicate. Scott R. Silverman,
Chairman and CEO of VeriChip, commented, "We believe the VeriMed
Patient Identification System is an essential health care solution
for at-risk patients, including diabetics, who tend to present with
various co-morbidities and medications, and are more frequently
admitted to emergency departments. Since the inception of the
VeriMed System, we always knew that the diabetic community was in
need of a way to communicate their medical information better and
more frequently. We will continue to focus on diabetics and to
enhance our relationship further with the American Diabetes
Association. The Atlanta Diabetes EXPO provides us direct access so
we can continue to educate an important target audience." The
Diabetes EXPO is a patient-driven tradeshow, including professional
speakers and a variety of ADA program/event information, where
exhibitors from pharmaceutical and medical device companies display
beneficial products for diabetics. The Diabetes EXPO began in 1995
in Phoenix, Arizona, and has grown to 18, metro, major and mid-size
cities around the U.S. The next event will be held in Boston on
March 17, 2007. About VeriChip Corporation VeriChip Corporation,
headquartered in Delray Beach, Florida, develops, markets and sells
radio frequency identification, or RFID, systems used to identify,
locate and protect people and assets. VeriChip's goal is to become
the leading provider of RFID systems for people in the healthcare
industry. VeriChip sells passive RFID systems for identification
purposes and active RFID systems for local-area location and
identification purposes. VeriChip recently began to market its
VeriMed(TM) Patient Identification System for rapidly and
accurately identifying people who arrive in an emergency room and
are unable to communicate. This system uses the first
human-implantable passive RFID microchip, the implantable
VeriChip(TM), cleared for medical use in October 2004 by the United
States Food and Drug Administration. VeriChip Corporation is
majority-owned by Applied Digital Inc. (NASDAQ:ADSX), which also
owns a majority position in Digital Angel Corporation (AMEX:DOC).
For more information on VeriChip, please call 1-800-970-2447, or
email . Additional information can be found online at
http://www.verichipcorp.com/. Statements about the Company's future
expectations, including future revenues and earnings, and all other
statements in this press release other than historical facts are
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Litigation
Reform Act of 1995. Such forward-looking statements involve risks
and uncertainties and are subject to change at any time, and the
Company's actual results could differ materially from expected
results. The Company undertakes no obligation to update
forward-looking statements to reflect subsequently occurring events
or circumstances. Contact: VeriChip Corporation Allison Tomek
561-805-8000 The Ruth Group Nick Laudico (investors) (646) 536-7030
Jason Rando (media) (646) 536-7025 DATASOURCE: VeriChip Corporation
CONTACT: Allison Tomek of VeriChip Corporation, +1-561-805-8000, ;
or Nick Laudico (investors), +1-646-536-7030, , or Jason Rando
(media), +1-646-536-7025, , both of The Ruth Group Web site:
http://www.verichipcorp.com/
Copyright
Applied Digital Solutions (NASDAQ:ADSX)
Historical Stock Chart
From Apr 2024 to May 2024
Applied Digital Solutions (NASDAQ:ADSX)
Historical Stock Chart
From May 2023 to May 2024